Ceradan

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ceradan

What is Ceradan? An Overview

Here's a quick reference for the fundamental properties of Ceradan:

Property Description
Active components Ceramide, Cholesterol, Free Fatty Acids (Physiological Lipid Blend)
Form Cream (semi-solid, viscous)
Pharmacological class Emollient, Lipid Replacement Therapy
General purpose Barrier Restoration and reduction of Transepidermal Water Loss (TEWL)
Origin Combination Product (Derived and natural components)

Definition and Pharmacological Classification

Ceradan is a specialized dermatological formulation classified as a Topical Moisturizer and a Barrier Repair Agent, intended exclusively for topical application onto the skin. It belongs to the high-level pharmacological class of Emollients and is defined as a type of Lipid Replacement Therapy because its function is to supplement essential components of the skin's barrier structure, addressing epidermal barrier dysfunction. The formulation is typically positioned for use across various age groups, including infants, reflecting a broad target age group due to its gentle composition.


Core Composition and General Purpose

The primary action of the product stems from its core composition: an optimised physiological blend of the three essential structural lipids found naturally in the skin: Ceramide (often provided as a synthetic analogue), Cholesterol, and Free Fatty Acids. This formulation is designed as a Combination Product that delivers these lipids in a specific structural ratio, aiming to replenish the barrier. This approach of restoring the complete lipid profile is recognized for its ability to improve skin barrier function and integrity.

This specific lipid mixture is essential for forming the orderly lipid lamellae, or water-sealing layers, within the skin's protective shield. The importance of these specific physiological lipids in restoring skin barrier function is a foundational element of the product's design. The general purpose of the formulation is, therefore, to promote Barrier Restoration, helping the skin reduce Transepidermal Water Loss (TEWL), which in turn helps relieve symptoms like associated roughness, sensitivity, and persistent dryness.

What side effects are possible with Ceradan?

Possible Side Effects and Safety Information

The regulatory safety profile for this Topical Emollient is primarily characterized by localized adverse reactions at the application site and specific contraindications. Because the formulation is composed of physiological lipids (Ceramide, Cholesterol, Free Fatty Acids), it is not associated with systemic adverse events, and therefore System-Organ Class (SOC) effects outside of the skin are not documented in official regulatory summaries.


Adverse Reaction Scope

Category Regulatory Status
Adverse Reaction Domain Skin and subcutaneous tissue disorders (Dermatological)
Systemic Effects None documented in official safety summaries.
Frequency Classification Adverse events are generally described using post-market surveillance notes rather than standard regulatory frequency categories (e.g., Common, Uncommon).

Documented Localized Reactions and Safety Constraints

The most commonly reported effects involve localized skin tolerance. These include transient burning sensation, local skin irritation, pruritus (itching), and erythema (redness) at the application site. These are often short-lived and may be more apparent when the product is applied to highly compromised skin. The most clinically significant, though rare, safety event is severe allergic contact dermatitis, indicating a hypersensitivity to a specific ingredient.

Safety Restrictions

The most stringent safety restriction is a Contraindication due to Hypersensitivity. The product must not be used in individuals with a known or suspected allergy to Ceramide, Cholesterol, Free Fatty Acids, or any other component in the cream formulation. The safety documentation is applicable to various populations, including infants and children, provided this core contraindication is respected.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documentation for this topical emollient, which is classified as a non-toxic, external-use preparation, indicates that no specific systemic signs or clinical symptoms of overdose resulting from typical application are formally documented. The product's intended non-systemic nature means that severe or life-threatening outcomes are not listed in official regulatory overdose profiles.

The regulatory guidance focuses on immediate management in the event of inappropriate exposure. The primary concern and official help-seeking trigger is accidental oral ingestion of the cream, a factor particularly relevant to the pediatric population. In such a circumstance, immediate medical attention is required. The explicit, mandated emergency procedure is to call a doctor or a poison control center right away for immediate professional assessment and advice.

Management is defined in regulatory documents as symptomatic and supportive treatment; no specific antidote is known or documented for the formulation. Furthermore, regulatory information does not stipulate pre-defined hospital monitoring or observation requirements, leaving such decisions to the discretion of the treating healthcare professional.

Therapeutic Uses of Ceradan

What Ceradan Treats: Main Uses and Benefits

The product is commonly used to address symptoms related to a compromised protective barrier where additional symptomatic support is needed. Ceramide-dominant emollients are considered relevant in conditions where functional stability becomes affected and may be part of symptomatic management for the condition, representing the core therapeutic domain of this product category.


Addressing Symptoms of Atopic Dermatitis and Eczema

This formulation is commonly used as a part of the therapeutic management for mild to moderate Atopic Dermatitis (Eczema), applied across domains where additional symptomatic support is needed for symptoms that interfere with daily functioning. This supportive therapy is commonly used across conditions presenting with symptomatic discomfort, including eczema, xerosis (chronic dryness), and the symptomatic management of sensitive skin. It is used to help with persistent pruritus (itching), the characteristic scaling, and roughness associated with recurrent episodic manifestations.

Supportive Relief for Chronic Dryness and Irritated Skin

The product is applied in situations involving significant chronic dryness, sensitivity, and irritation linked to an impaired barrier function. By assisting with maintenance, it helps ease the symptoms related to dehydration and chronic dryness, providing support that helps ease the overall symptom burden. This structural support contributes to improved comfort during symptomatic periods, which is particularly relevant for sensitive skin populations, including newborns and infants.


Quick Fact: Relief for Persistent Dryness The formulation is commonly used when symptoms relate to structural barrier deficits, helping ease the overall symptom load associated with dryness and irritation.

Eligibility and Restrictions for Use

Who Can and Cannot Use Ceradan?

The population eligibility for Ceradan is defined by its regulatory classification as a topical emollient and barrier repair agent, which results in broad inclusion across demographics. This classification means the product typically lacks the extensive systemic restrictions found in prescription drug labels.


Official Eligibility Profile

Category Regulatory Statement/Finding
Populations Allowed The product is officially allowed for use in all age groups, including infants, children, and adults, based on its formulation as a gentle barrier repair agent.
Contraindicated Populations Use is contraindicated only in individuals with a known hypersensitivity or allergy to any of the specific ingredients in the formulation.
Age-Related Restrictions No minimum age restriction is documented; it is appropriate for all age groups.
Systemic Restrictions None documented. Formal restrictions based on hepatic impairment, renal impairment, or specific Pregnancy and Lactation Risk Categories are not required or specified in the official labeling for this non-systemic product class.

Connection to the Eligibility Profile

Official regulatory information establishes that the only absolute exclusion is known hypersensitivity to the product's components. Its non-systemic application and broad approval mean that restrictions related to internal organ function or systemic disease are not cited in regulatory documents for determining eligibility.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Ceradan is strictly determined by its classification as a topical emollient containing physiological lipids (Ceramide, Cholesterol, and Free Fatty Acids). As stated in authoritative government regulatory sources, products applied locally with minimal systemic absorption are not typically associated with formal pharmacokinetic or pharmacodynamic interactions.

Official Regulatory Status Summary

Interaction Category Regulatory Finding (Based on Official Labeling)
Contraindicated Combinations No co-administered substances are formally listed as prohibited.
Metabolic Interactions (CYP/Transporters) No systemic metabolic interactions are documented in the prescribing information.
Drug Exposure Modification No documented alteration of drug plasma concentrations is cited.
Timing Separation Rules No mandatory administration timing requirements are specified.
Food, Alcohol, or Supplements No formal interactions with these substances are documented.

Summary of the Official Interaction Profile The official regulatory documentation issued by government health authorities does not cite any specific systemic drug-drug interactions for this product. Consequently, the interaction profile contains no statements regarding effects on metabolic enzymes or drug transporters. The absence of documented systemic interactions means that the official context contains no required timing restrictions or contraindicated combinations with other medicines based on interaction risk.

Mechanism of Action

Ceradan's mechanism of action involves dual-target modulation within the stratum corneum, the outermost layer of the epidermis. The primary component is a physiologic lipid mixture consisting of ceramides, cholesterol, and free fatty acids in a specific 3:1:1 mass ratio.

This mixture delivers exogenous essential lipids into the stratum corneum. Upon application, the lipids penetrate and integrate into the intercellular lamellar structures of the keratinocytes, replenishing depleted endogenous ceramide and cholesterol levels. This systemic incorporation of lipids stabilizes the lamellar bilayer, resulting in a restoration of the skin's inherent permeability barrier function and a reduction in transepidermal water loss (TEWL).

Secondly, certain formulations contain an Active pH Control system, utilizing agents such as zinc lactobionate. This system acts as a topical pH buffering agent, inducing a sustained reduction in the local pH of the stratum corneum towards the normal acidic range ( pH 4.5 -6.0). This acidification step modulates molecular and intracellular pathways by inhibiting the excessive activity of specific serine proteases. The decreased protease activity subsequently supports an increase in the synthesis and secretion of endogenous skin lipids, further contributing to the functional and structural integrity of the epidermal barrier.

Dosage and Administration Information

Administration Guidelines

This section details the usage instructions for Ceradan.


Administration Scope

The route of administration for this product is topical application to the skin (for external use only). The administration is typically performed twice daily, which defines the frequency pattern for its use. The product is intended for regular use, which indicates a continuous and consistent course duration rather than short-term or acute application.

Procedural Element Instruction
Route of Administration Topical application to the skin (External use only)
Dosing Schedule Apply a thin layer
Frequency Twice daily and regularly
Targeted Area All skin areas, including the face

Procedural Steps

Proper use follows a defined sequence of steps to ensure correct administration. Before applying the product, ensure the skin is clean, dry, and intact. The use protocol involves applying the product to the targeted area, followed by a gentle massage to aid absorption. Hand hygiene is specified as a step, involving washing hands before and after use. Furthermore, maintenance steps, such as securely replacing the cap tightly after each use, are included. Storage conditions involve keeping the product in a cool and dry place, away from direct sunlight.


Connection to the Use Protocol

These instructions collectively structure the use of the product by defining the topical route, standardizing the application frequency to twice daily, and describing a regimen of continuous, regular use. The steps specify the condition of the skin prior to application (clean and dry) and include necessary hygiene measures (hand washing) to guide standardized administration.

Recent Clinical Evidence

Research evidence / Overview of studies for Ceradan

This section summarizes the structure of the available scientific research for this product, focusing on the conditions, outcomes, and populations that researchers have studied and monitored. The evidence describes group patterns observed in the studies but does not determine whether an individual will respond similarly or offer any clinical recommendations.

Evidence for Use in Atopic Dermatitis (Eczema)

Research was studied for its use in conditions characterized by fluctuating or episodic manifestations, specifically Atopic Dermatitis (Eczema). The evidence base includes short-term Randomized Controlled Trials (RCTs) and systematic reviews exploring the role of this specific physiological lipid formulation, often evaluated in studies as a component of supportive care.

The studies primarily examined specific outcomes related to physical discomfort, such as changes in standardized eczema severity scores and tracking symptoms like pruritus (itching) and scaling. Findings describe patterns observed in the studies concerning these severity measures and the incidence of outcomes capturing phases of heightened symptom activity (flare-ups). The research also included studies that evaluated this formulation against other topical emollients.

A key limitation is that the follow-up durations were limited in many primary symptom-focused RCTs, which typically tracked changes over periods of six weeks or less. Additionally, when looking at the broader scientific literature, systematic reviews often group data from different ceramide-dominant formulations. This can introduce heterogeneity, meaning the evidence quality varies across studies and making it difficult to isolate findings specifically tied to this product's precise lipid ratio.

Evidence for Skin Barrier Restoration and Chronic Dryness

The product was evaluated in studies dedicated to its function as a lipid replacement therapy for skin barrier health, relevant in conditions where symptoms may vary in intensity such as chronic dryness (xerosis).

The research examined core biophysical measurements. Studies monitored the skin barrier integrity marker, Transepidermal Water Loss (TEWL), and outcomes related to systemic or functional imbalance, such as changes in skin hydration levels. Data show patterns related to a reduction in TEWL and changes in skin hydration in the observed populations. This evidence primarily contributes to the broader evidence landscape by using objective physiological measures to track skin surface changes.

Follow-up Duration and Longer-Term Observation

Studies research examined different time intervals for monitoring changes. While many studies assess short-term symptom changes over a few weeks, some prospective studies have monitored outcomes over defined time intervals of several months. The evidence describes patterns in biophysical markers observed over these medium-term study periods. However, long-term effects are not fully established, and there is limited information for long-term outcomes that track the durability of response or product use over many years.

Key Studies & References

  1. Optimizing the physiological lipid mixture for barrier repair

Frequently Asked Questions (FAQ)

Common questions about Ceradan (FAQ)


Q: Is Ceradan considered a medicine, a moisturizer, or a medical device in official documents?

Official classification documents describe the product code associated with Ceradan as a medical device subject to specific regulatory controls. Furthermore, the formulation is broadly classified as a topical emollient and a barrier repair agent, intended for external use on the skin.


Q: What is the main difference between Ceradan and a regular cosmetic moisturizer?

The formulation is distinguished by its specific components and mechanism of action, as described in product documents. It contains a specific 3:1:1 mass ratio of physiological lipids (Ceramide, Cholesterol, and Free Fatty Acids), which is designed to actively replenish the skin barrier. Some variants also include a patented Active pH Control system, which supports the skin's natural repair process.


Q: Does Ceradan have a safety classification for long-term use?

Administration instructions specify that the product is intended for regular use. However, research evidence indicates that while medium-term observations exist, information on the durability of response or use over many years is limited in the available clinical studies.


Q: How quickly does official research suggest the product starts working to help with itchiness?

Clinical studies have examined outcomes related to changes in symptoms such as itching over short-term follow-up periods. These research intervals typically range up to six weeks to observe initial patterns of improvement.


Q: Can Ceradan be used alongside steroid creams, according to official descriptions?

Official regulatory documentation does not cite any specific timing restrictions or contraindications regarding the use of this product alongside other topical medicines, including steroid creams. This is because the product is an emollient with minimal systemic absorption.


Q: Do studies mention any potential issues when Ceradan is used on broken or cracked skin?

Administration guidelines typically specify application to intact skin. However, safety documentation also notes that the most commonly reported localized effects, such as transient burning, may be more apparent when the product is applied to highly compromised skin.


Q: Is there a version of Ceradan specifically formulated for children or babies?

The official eligibility profile indicates that the general cream formulation is allowed for use in all age groups, including infants and children. While other product variations (such as washes or gels) exist for different needs, the main cream is described as suitable for infants.


Q: Does the cream contain any steroids, according to the manufacturer's official information?

Official product labeling lists the active components as the three physiological lipids (Ceramide, Cholesterol, and Free Fatty Acids). Steroids are not listed among the ingredients in the cream formulation.


Q: Is Ceradan labeled as fragrance-free or hypoallergenic in official regulatory documents?

Official product descriptions and labeling generally describe the product as fragrance-free. This characteristic, along with its composition, categorizes it as suitable for sensitive skin.


Q: What is the expected duration of the skin barrier repair process mentioned in clinical studies?

Clinical studies monitor the skin barrier integrity marker, called Transepidermal Water Loss (TEWL), over defined study periods. These observation periods include short-term intervals of a few weeks and medium-term intervals of several months to track changes.


Q: Does Ceradan contain menthol, and what is the purpose of that ingredient in the formulation?

Menthol is not listed as an ingredient in the standard Skin Barrier Repair Cream formulation. However, menthol is listed as a component in the Soothing Gel formulation, where it is included to provide a cooling sensation.


Q: What is the main purpose of Ceradan Soothing Gel compared to the Skin Barrier Repair Cream?

Both the Soothing Gel and the Cream contain the core 3:1:1 lipid ratio for barrier repair. The key functional difference is that the Soothing Gel formulation includes specific ingredients to provide a cooling sensation, which is designed for targeted relief.


Q: Is Ceradan considered gluten-free or suitable for people with certain dietary restrictions?

The core components of the cream are physiological lipids. Product information often describes the formulation as gluten-free based on the absence of added wheat-related ingredients.


Q: Can Ceradan be used by pregnant or breastfeeding individuals, according to official guidance?

Due to its non-systemic application as a topical product, official labeling typically does not specify formal restrictions or risk categories related to Pregnancy and Lactation. Eligibility is primarily determined by the absence of known ingredient hypersensitivity.


Q: Is there a risk of skin irritation from Ceradan's preservatives or stabilizers?

The most common documented adverse effects are localized reactions, including general skin irritation or a transient burning sensation. The single stringent safety restriction is a known hypersensitivity or allergy to any component, which includes non-lipid excipients.


Q: Is the Ceradan formula the same across all product types (cream, gel, wash)?

The formula varies across the product range. While all products in the Ceradan range are described as containing the 3:1:1 lipid ratio described for barrier repair, the remaining components (e.g., surfactants in the wash or cooling agents in the gel) differ according to the product's intended function.


Q: What is the difference between Ceradan and other brands that also contain ceramides?

The formulation is specifically defined by its adherence to a precise structural ratio of 3:1:1 (Ceramide: Cholesterol: Free Fatty Acids). Additionally, some products in the range include a patented Active pH Control system.


Q: Does Ceradan contain common irritants like Sodium Lauryl Sulfate (SLS) or alcohol?

The ingredients list for the cream does not contain Sodium Lauryl Sulfate (SLS). The cream does contain fatty alcohols (e.g., Cetyl Alcohol), which are distinct from the drying alcohols sometimes found in products.


Q: What information is available regarding the long-term maintenance phase after initial skin repair?

The product is intended for regular use, which defines a continuous course duration. Studies describe patterns in biophysical markers observed over medium-term study periods of several months. The evidence for the durability of response over many years is limited.


Q: What are the general recommendations for when to apply Ceradan relative to bathing or showering?

The official procedural steps require that the product is applied to skin that is clean and dry prior to application.


Q: Is Ceradan available over-the-counter, or does it require a prescription in different regions?

Due to its regulatory classification as a non-prescription topical emollient or medical device, the product is typically available over-the-counter (OTC) in most regions, meaning it does not require a medical prescription.


Q: What are the main skin conditions that official sources describe Ceradan as being for?

Clinical studies have examined its use as a barrier repair agent in conditions characterized by barrier dysfunction. These conditions include Atopic Dermatitis (Eczema) and Chronic Dryness (Xerosis).


Q: Is there official information available regarding Ceradan's ingredients and known allergens?

Regulatory safety restrictions state the product is contraindicated in individuals with a known or suspected hypersensitivity or allergy to any component in the formulation. This includes the core lipids as well as any other excipients.

How should Ceradan be stored and disposed of?

Official Storage and Handling Requirements

Storage of this product must adhere strictly to the temperature conditions specified in regulatory labeling to maintain stability. The cream must be stored at room temperature within a defined range of 15 C to 30 C (59 F to 86 F).

Requirement Official Rule
Temperature Store between 15 C and 30 C
Container Integrity Do not use if the seal is damaged
Child Safety Keep out of reach of children

Crucially, the packaging is tamper-evident, and the product should not be used if the seal is compromised. A mandatory safety instruction requires keeping the cream out of the sight and reach of children. Regulatory labeling does not provide specific instructions for the household disposal of unused or expired product.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Ceradan found in:

A-Z Index: